ask="N/A"
ask_size="N/A"
average_daily_volume="457818"
bid="55.00"
bid_size="4900"
book_value="11.49"
change="+0.59"
change_from_200_day_moving_average="6.47"
change_from_50_day_moving_average="4.24"
change_from_52_week_high="-9.30"
change_From_52_week_low="30.95"
change_in_percent="+0.77%"
close="77.47"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-6.21"
ebitda="-244.58M"
eps_estimate_current_year="-7.11"
eps_estimate_next_quarter="-1.78"
eps_estimate_next_year="-6.45"
ex_dividend_date="N/A"
float_shares="38556000"
high="77.57"
high_52_weeks="86.77"
last_trade_date="2/24/2017"
last_trade_price="77.47"
last_trade_size="10246"
last_trade_time="4:00pm"
low="73.69"
low_52_weeks="46.52"
market_capitalization="3.23B"
moving_average_200_day="71.00"
moving_average_50_day="73.23"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="94.69"
open="75.90"
pe_ratio="N/A"
peg_ratio="-0.36"
percent_change_from_200_day_moving_average="+9.11%"
percent_change_from_50_day_moving_average="+5.79%"
percent_change_from_52_week_high="-10.72%"
percent_change_from_52_week_low="+66.53%"
previous_close="76.88"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.69"
price_per_sales="24119.51"
revenue="133000.00"
shares_outstanding="41726000"
short_ratio="15.47"
stock_exchange="NMS"
symbol="RARE"
volume="280005"
weeks_range_52="46.52 - 86.77"
